Concepedia

Kamunkhwala Gausi

KG

Statistics

Publications

8

Citations

168

H-Index

8

Active since

2013

Affiliations

University of Cape Town(Current)

Johns Hopkins University

Frontier Science & Technology Research Foundation, Inc.

Stellenbosch University

Johns Hopkins Medicine

Kamunkhwala Gausi is an author at University of Cape Town specializing in clinical pharmacology, tuberculosis pharmacotherapy, and pharmacology.

ORCID

Publications per year

2013–2024

8

Publications

8

Pharmacokinetics and Drug‐Drug Interactions of Isoniazid and Efavirenz in Pregnant Women Living With HIV in High TB Incidence Settings: Importance of Genotyping

Kamunkhwala Gausi, Lubbe Wiesner, Jennifer Norman et al. · Clinical Pharmacology & Therapeutics · 2020 · 36 citations · Full text

, , +16

Risk factors for anemia in children under 6 years of age in Ethiopia: analysis of the data from the cross-sectional Malaria IndicatorSurvey, 2007

Richard Reithinger, Jeremiah Ngondi, Patricia M. Graves et al. · Transactions of the Royal Society of Tropical Medicine and Hygiene · 2013 · 27 citations · Full text

, , +16

Pharmacokinetics and Target Attainment of SQ109 in Plasma and Human-Like Tuberculosis Lesions in Rabbits

Oluwaseun Francis Egbelowo, Jansy P. Sarathy, Kamunkhwala Gausi et al. · Antimicrobial Agents and Chemotherapy · 2021 · 25 citations · Full text

, , +8

Decreased Dolutegravir and Efavirenz Concentrations With Preserved Virological Suppression in Patients With Tuberculosis and Human Immunodeficiency Virus Receiving High-Dose Rifampicin

Christine Sekaggya‐Wiltshire, Ruth Nabisere, Joseph Musaazi et al. · Clinical Infectious Diseases · 2022 · 22 citations · Full text

, , +17

Bedaquiline exposure in pregnancy and breastfeeding in women with rifampicin‐resistant tuberculosis

Richard Court, Kamunkhwala Gausi, Buyisile Mkhize et al. · British Journal of Clinical Pharmacology · 2022 · 19 citations · Full text

, , +17

1–5 of 8